Literature DB >> 12068058

Oxidative capacity interacts with oxygen delivery to determine maximal O(2) uptake in rat skeletal muscles in situ.

Russell T Hepple1, Jason L Hagen, Dan J Krause.   

Abstract

Based on proportional changes in V(O(2))(,max) with alterations in O(2) delivery, it is widely held that O(2) availability limits V(O(2))(,max). In contrast, reductions in V(O(2))(,max) are also seen when mitochondrial oxidative capacity is reduced. Taken collectively, these prior results are consistent with the notion that there is not a single-step limitation to V(O(2))(,max). We used a pump-perfused rat hindlimb model to test the hypothesis that combining moderate reductions in O(2) delivery and mitochondrial oxidative capacity would yield a greater reduction in V(O(2))(,max) than seen when performing each intervention independently, demonstrating an interaction between O(2) supply and mitochondrial oxidative capacity in determining V(O(2))(,max). Four groups of animals were studied: two in high O(2) delivery conditions (hindlimb O(2) delivery: 88 +/- 1 micromol O(2) min(-1); mean +/- S.E.M.) and two in moderately reduced O(2) delivery conditions (66 +/- 2 micromol O(2) min(-1)). One group at each level of O(2) delivery was treated with 0.1 microM myxothiazol to reduce mitochondrial oxidative capacity via competitive inhibition of NADH cytochrome c reductase. V(O(2))(,max) in control animals (no myxothiazol) was 29 % lower in the moderately reduced O(2) delivery group (592 +/- 24 mmol O(2) min(-1) (100 g)(-1)); P < 0.05) than in the high O(2) delivery group (833 +/- 63 micromol O(2) min(-1) (100 g)(-1)). Similarly, V(O(2))(,max) was reduced by 29 % (594 +/- 22 micromol O(2) min(-1) (100 g)(-1)); P < 0.05) in myxothiazol-treated animals in high O(2) delivery conditions compared to control animals in high O(2) delivery conditions. When myxothiazol treatment was combined with moderately reduced O(2) delivery, V(O(2))(,max) was reduced by an additional 18 % (484 +/- 21 micromol O(2) min(-1) (100 g)(-1)); P < 0.05) compared to either intervention performed independently. These results show that O(2) supply and mitochondrial oxidative capacity interact to determine V(O(2))(,max).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068058      PMCID: PMC2290376          DOI: 10.1113/jphysiol.2001.013649

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

Review 1.  Limiting factors for maximum oxygen uptake and determinants of endurance performance.

Authors:  D R Bassett; E T Howley
Journal:  Med Sci Sports Exerc       Date:  2000-01       Impact factor: 5.411

Review 2.  Adaptations of skeletal muscle to endurance exercise and their metabolic consequences.

Authors:  J O Holloszy; E F Coyle
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-04

3.  Biochemical adaptation of mitochondria, muscle, and whole-animal respiration to endurance training.

Authors:  K J Davies; L Packer; G A Brooks
Journal:  Arch Biochem Biophys       Date:  1981-07       Impact factor: 4.013

4.  Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps.

Authors:  R S Richardson; B Grassi; T P Gavin; L J Haseler; K Tagore; J Roca; P D Wagner
Journal:  J Appl Physiol (1985)       Date:  1999-03

5.  Muscular blood flow distribution patterns as a function of running speed in rats.

Authors:  M H Laughlin; R B Armstrong
Journal:  Am J Physiol       Date:  1982-08

6.  Aerobic capacity during acute exposure to simulated altitude, 914 to 2286 meters.

Authors:  R W Squires; E R Buskirk
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

7.  Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.

Authors:  K Gerth; H Irschik; H Reichenbach; W Trowitzsch
Journal:  J Antibiot (Tokyo)       Date:  1980-12       Impact factor: 2.649

8.  Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of th respiratory chain.

Authors:  G Thierbach; H Reichenbach
Journal:  Biochim Biophys Acta       Date:  1981-12-14

9.  Significance of skeletal muscle oxidative enzyme enhancement with endurance training.

Authors:  P D Gollnick; B Saltin
Journal:  Clin Physiol       Date:  1982-02

10.  Design of the mammalian respiratory system. IX. Functional and structural limits for oxygen flow.

Authors:  E R Weibel; C R Taylor; P Gehr; H Hoppeler; O Mathieu; G M Maloiy
Journal:  Respir Physiol       Date:  1981-04
View more
  6 in total

1.  Intermittent pneumatic leg compressions acutely upregulate VEGF and MCP-1 expression in skeletal muscle.

Authors:  Bruno T Roseguini; S Mehmet Soylu; Jeffrey J Whyte; H T Yang; Sean Newcomer; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-26       Impact factor: 4.733

2.  Hypothermia Decreases O2 Cost for Ex Vivo Contraction in Mouse Skeletal Muscle.

Authors:  Patrick J Ferrara; Anthony R P Verkerke; Jeffrey J Brault; Katsuhiko Funai
Journal:  Med Sci Sports Exerc       Date:  2018-10       Impact factor: 5.411

3.  Maximal exercise and muscle oxygen extraction in acclimatizing lowlanders and high altitude natives.

Authors:  Carsten Lundby; Mikael Sander; Gerrit van Hall; Bengt Saltin; José A L Calbet
Journal:  J Physiol       Date:  2006-03-31       Impact factor: 5.182

4.  Distinguishing the effects of convective and diffusive O₂ delivery on VO₂ on-kinetics in skeletal muscle contracting at moderate intensity.

Authors:  Jessica Spires; L Bruce Gladden; Bruno Grassi; Matthew L Goodwin; Gerald M Saidel; Nicola Lai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-12       Impact factor: 3.619

5.  Evidence of a metabolic reserve in the skeletal muscle of elderly people.

Authors:  Gwenael Layec; Joel D Trinity; Corey R Hart; Yann Le Fur; Jacob R Sorensen; Eun-Kee Jeong; Russell S Richardson
Journal:  Aging (Albany NY)       Date:  2016-11-06       Impact factor: 5.682

6.  Diagnostic reference values for sarcopenia in Tibetans in China.

Authors:  Liping Ye; Youfeng Wen; Ying Chen; Jie Yao; Xin Li; Yingying Liu; Jia Song; Zhengqi Sun
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.